ABPI’s Sheuli Porkess on how COVID-19 could improve clinical...

COVID-19 has shifted the global gaze onto the topic of medical research – and is starting to transform the way we see and do clinical trials.

Pharma given COVID-19 test 'call to arms' by health secretar...

UK health secretary Matt Hancock has asked pharma and biotech firms to help the country find antibody tests that work against COVID-19 in a bid to find an exit strategy from the lockdown th

Sunak's first budget tackles pharma R&D as well as coronavir...

In his first budget as UK chancellor, Rishi Sunak’s main focus was to prepare the country for the impact of coronavirus – but there were other pharma-friendly measures in there too.

Future proofing the UK’s research ecosystem in the face of g...

The UK is a powerhouse of clinical research but maintaining that leading position – and all the benefits that come with it – in the face of global change requires adaptation.

ABPI looks internally for new CEO, naming Richard Torbett

ABPI’s blueprint to build a pharma powerhouse in uncertain p...

The UK is in the grips of election fever, but whoever takes the reins on 13 December will need to “build a thriving environment for medicines discovery” if they want to improve health outco